Outcomes for B-precursor patients in legacy Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) studies in childhood Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group (COG) report

被引：0
|
作者：
Gaynon, Paul S. [1 ]
Camitta, Bruce C. [1 ]
Matloub, Yousif [1 ]
Martin, Paul L. [1 ]
Winick, Naomi [1 ]
Seibel, Nita L. [1 ]
Bowman, W. Paul [1 ]
Sather, Harland N. [1 ]
Devidas, Meenakshi [1 ]
Hunger, Stephen [1 ]
Carroll, William L. [1 ]
机构：
[1] Childrens Oncol Grp, Arcadia, CA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.847.847
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
847
引用
收藏
页码：260A / 260A
页数：1
相关论文
共 50 条
  • [1] High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative
    Sutcliffe, MJ
    Shuster, JJ
    Sather, HN
    Camitta, BM
    Pullen, J
    Schultz, KR
    Borowitz, MJ
    Gaynon, PS
    Carroll, AJ
    Heerema, NA
    LEUKEMIA, 2005, 19 (05) : 734 - 740
  • [2] High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative
    M J Sutcliffe
    J J Shuster
    H N Sather
    B M Camitta
    J Pullen
    K R Schultz
    M J Borowitz
    P S Gaynon
    A J Carroll
    N A Heerema
    Leukemia, 2005, 19 : 734 - 740
  • [3] Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
    Schultz, Kirk R.
    Pullen, D. Jeanette
    Sather, Harland N.
    Shuster, Jonathan J.
    Devidas, Meenakshi
    Borowitz, Michael J.
    Carrol, Andrew J.
    Heerema, Nyla A.
    Rubnitz, Jeff Rey E.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    Gaynon, Paul S.
    Camitta, Bruce M.
    BLOOD, 2007, 109 (03) : 926 - 935
  • [4] Biology-driven classification of childhood acute lymphoblastic leukemia: A combined analysis of prognostic markers from the pediatric oncology group (POG) and children's cancer group (CCG).
    Schultz, KR
    Pullen, J
    Sather, H
    Shuster, J
    Borowitz, MJ
    Heerema, NA
    Carroll, AJ
    Gaynon, PS
    Camitta, BM
    BLOOD, 2004, 104 (11) : 151A - 151A
  • [5] Sex-Based Disparities in Outcome in Childhood Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group (COG) Report
    Gupta, Sumit
    Teachey, David T.
    Devidas, Meenakshi
    Chen, Zhiguo
    Dunsmore, Kimberly P.
    Larsen, Eric C.
    Maloney, Kelly
    Mattano, Leonard A.
    Winter, Stuart S.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Borowitz, Michael J.
    Wood, Brent L.
    Carroll, William L.
    Winick, Naomi J.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Hunger, Stephen P.
    BLOOD, 2020, 136
  • [6] Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Davies, Stella M.
    Borowitz, Michael J.
    Rosner, Gary L.
    Ritz, Kristin
    Devidas, Meenakshi
    Winick, Naomi
    Martin, Paul L.
    Bowman, Paul
    Elliott, James
    Willman, Cheryl
    Das, Soma
    Cook, Edwin H.
    Relling, Mary V.
    BLOOD, 2008, 111 (06) : 2984 - 2990
  • [7] Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group
    Lange, Beverly J.
    Smith, Franklin O.
    Feusner, James
    Barnard, Dorothy R.
    Dinndorf, Patricia
    Feig, Stephen
    Heerema, Nyla A.
    Arndt, Carola
    Arceci, Robert J.
    Seibel, Nita
    Weiman, Margie
    Dusenbery, Kathryn
    Shannon, Kevin
    Luna-Fineman, Sandra
    Gerbing, Robert B.
    Alonzo, Todd A.
    BLOOD, 2008, 111 (03) : 1044 - 1053
  • [8] Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Mehta, P. A.
    Davies, S. M.
    Kumar, A.
    Devidas, M.
    Lee, S.
    Zamzow, T.
    Elliott, J.
    Villanueva, J.
    Pullen, J.
    Zewge, Y.
    Filipovich, A.
    LEUKEMIA, 2006, 20 (09) : 1539 - 1541
  • [9] Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
    P A Mehta
    S M Davies
    A Kumar
    M Devidas
    S Lee
    T Zamzow
    J Elliott
    J Villanueva
    J Pullen
    Y Zewge
    A Filipovich
    Leukemia, 2006, 20 : 1539 - 1541
  • [10] Treatment of high risk T-cell acute lymphoblastic leukemia (TALL): Comparison of recent experience of the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG).
    Seibel, NL
    Asselin, BL
    Nachman, JB
    Steinherz, P
    Camitta, B
    Devidas, M
    Sather, HN
    BLOOD, 2004, 104 (11) : 195A - 196A
12345